adagrasib
mirati
['krystal-1', 'sclc', 'nsclc', 'adagrasib']
so excited to kick off the asco annual meeting with presenting the krystal-1 study evaluating the activity and safety of adagrasib in nsclc krasg12c. 
Dr. Patt is a med onc, healthcare informatics specialist, and health policy expert @TexasOncology @TheUSONetwork @DellMedSchool.  All views are my own.